Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 31 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

31 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Feb. 1, 2024 CNSP P 166,666 $0.30 $50,000 215,676 Direct +340.07% Acquired -99.9% (price as of 2026-10-02)
Aug. 16, 2023 CNSP P 2,750 $1.80 $4,950 49,010 Direct +5.94% Acquired -100.0% (price as of 2026-10-02)
April 12, 2023 CNSP P 15,000 $0.69 $10,350 45,010 Direct +49.98% Acquired -100.0% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Nov. 17, 2025 CNSP Option to purchase common stock Common Stock (9,761) $30.00 Nov. 17, 2035 9,761 Acquired
Nov. 12, 2025 MBRX Stock Options (right to buy) Common Stock (150,000) $0.49 Nov. 12, 2035 150,000 Acquired
Nov. 4, 2024 MBRX Stock option (right to buy) Common Stock (10,000) $2.45 Nov. 4, 2034 10,000 Acquired
April 8, 2024 CNSP Option to purchase common stock Common Stock (83,000) $0.26 April 8, 2034 83,000 Acquired
April 8, 2024 CNSP Restricted Stock Units Common Stock (83,000) · · 83,000 Acquired
Feb. 1, 2024 CNSP Series A Warrant to purchase common stock Common Stock (166,666) $0.30 Feb. 1, 2029 166,666 Acquired
Feb. 1, 2024 CNSP Series B Warrant to purchase common stock Common Stock (166,666) $0.30 Oct. 1, 2025 166,666 Acquired
May 25, 2023 MBRX Stock option (right to buy) Common Stock (15,000) $0.62 May 25, 2033 15,000 Acquired
April 28, 2023 CNSP Restricted Stock Units Common Stock (1,250) · · 1,250 Disposed
March 29, 2023 CNSP Restricted Stock Units Common stock (16,467) · · 16,467 Acquired
June 20, 2022 MBRX Stock option (right to buy) Common Stock (23,333) $1.49 June 20, 2032 23,333 Acquired
June 20, 2022 MBRX Stock option (right to buy) Common Stock (15,000) $1.49 June 20, 2032 15,000 Acquired
April 28, 2022 CNSP Restricted Stock Units Common Stock (600,000) · · 600,000 Acquired
June 7, 2021 MBRX Stock option (right to buy) Common Stock (10,000) $3.95 June 7, 2031 10,000 Acquired
Feb. 5, 2021 CNSP Option to purchase common stock (right to buy) Common Stock (310,000) $3.36 Feb. 5, 2031 310,000 Acquired
June 15, 2020 MBRX Stock option (right to buy) Common Stock (15,000) $1.12 June 15, 2030 15,000 Acquired
July 11, 2019 MBRX Stock option (right to buy) Common Stock (35,000) $1.31 July 11, 2029 35,000 Acquired
May 22, 2019 MBRX Stock option (right to buy) Common Stock (15,000) $1.15 May 22, 2029 15,000 Acquired
June 6, 2018 MBRX Stock option (right to buy) Common Stock (35,000) $1.82 June 6, 2028 35,000 Acquired
July 24, 2017 MBRX Option to purchase common stock Common Stock (20,000) $1.87 July 24, 2027 20,000 Acquired
Sept. 18, 2014 PESI Stock Option Common Stock (2,400) $3.70 Sept. 18, 2024 2,400 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 3 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
Nov. 8, 2019 CNSP Common Stock [F1] 900,000 Direct
Nov. 8, 2019 CNSP Option to purchase common stock (right to buy)→ Common Stock (439,500) 439,500 Direct
Oct. 15, 2013 PESI Stock Option→ Common Stock (30,000) 30,000 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

CNSP

CEO
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2025 $580,000 · · $269,591 $319,000 · · $1,168,591
2024 $525,000 · · $292,863 $285,863 · · $1,103,680
2023 $525,000 · $20,688 · $60,638 · · $624,348

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.